Bengaluru, India – September 9, 2026: Infosys Foundation, the philanthropic and CSR arm of Infosys, today announced the inauguration of an exclusive cardio-obstetric outpatient unit and a state-of-the-art cardio obstetric catheterization laboratory at the Institute of Cardiology at the Rajiv Gandhi Government General Hospital (RGGGH), in Chennai, which is run by the Madras Medical College (MMC). These two units will help strengthen the cardio-obstetric care at RGGGH and help alleviate maternal mortality caused by heart-related diseases.
The inauguration ceremony was graced by Dr. K. G. Arunraj, Hon’ble Minister for Health, Medical Education and Family Welfare, Government of Tamil Nadu; Dr. Darez Ahamed, IAS, Secretary to Government, Health and Family Welfare Department, Government of Tamil Nadu; Dr. K. Shantharaman, Dean, Madras Medical College (MMC) and Rajiv Gandhi Government General Hospital (RGGGH), Chennai; and Mr. Anil Kumar P. N., Senior Vice President and Center Head, Chennai, Infosys, along with senior officials and executives from MMC and RGGGH.
This initiative is part of a broader collaboration between Infosys Foundation and MMC, which runs multiple healthcare facilities in Chennai, including the Institute of Social Obstetrics and the Government Kasturba Gandhi Hospital for Women and Children. In August 2024, Infosys Foundation inaugurated a special facility at the Institute of Social Obstetrics that is equipped with a high-risk antenatal ward and other critical care facilities to address cardiac complications among pregnant women.
Infosys Foundation has given a grant of over INR 31 crore to help strengthen MMC’s cardio-obstetric care facilities across its hospitals. In addition, the grant will also contribute towards managing patients under MMC’s internationally acclaimed research program – the National Pregnancy and Cardiac Diseases (NPAC) study, the largest global single-center study on pregnancy-related heart disease, and the Tamil Nadu Pregnancy and Heart Disease Registry (TNPHDR), which is the largest registry in this world in this domain. The main objective of this study is to develop a care protocol for heart disease in pregnancy and evaluate its effectiveness in improving pregnancy outcomes.
Sunil Kumar Dhareshwar, Trustee, Infosys Foundation, said, “Infosys Foundation is committed to addressing healthcare challenges and enabling initiatives towards the care and support for women’s health. With the inauguration of these units at the Rajiv Gandhi Government General Hospital, we aim to enhance maternal care by addressing the rising concern of cardiac complications during pregnancy. Our support not only aims to reduce maternal mortality but also contributes to research that will drive better healthcare solutions for women across the country.”
Dr.K. Shantaraman, Director and Dean of Madras Medical College (MMC), said, “We thank Infosys Foundation for their steadfast support in helping us scale the cardio-obstetric care for pregnant women across our facilities. The new units at the Rajiv Gandhi Government General Hospital, will further establish MMC as a national and international leader in maternal healthcare and research, offering innovative care models to address emerging healthcare challenges.”
About Infosys Foundation
Established in 1996, Infosys Foundation supports programs in the areas of education, healthcare, women empowerment, and environmental sustainability, amongst others. Its mission is to work with the underprivileged across the country and strive towards a more equitable society. Infosys Foundation takes pride in working with all sections of society, selecting projects with infinite care, and working in areas that are traditionally overlooked by society at large.
For more details, please log on: https://www.infosys.com/infosys-foundation
About Infosys
Infosys (NSE, BSE, NYSE: INFY) is a global leader in AI first business consulting and technology services. Over 325,000 of our people work to amplify human potential and create the next opportunity for people, businesses, and communities. As navigators of enterprise transformation, we enable businesses in 59 countries to unlock AI value at scale. With over four decades of experience in managing the systems and workings of global enterprises, we accelerate business transformation through our AI-first value
framework, deep domain expertise, and our unique ability to orchestrate innovations from our AI-native partner ecosystem. Infosys is recognized as the fastest growing IT services brand globally, committed to being a well-governed, environmentally sustainable partner for our clients where deep talent expertise, in an inclusive workplace, help them navigate their next.
Safe Harbor
Certain statements in this release concerning our future growth prospects, or our future financial or operating performance, are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the execution of our business strategy, increased competition for talent, our ability to attract and retain personnel, increase in wages, investments to reskill our employees, our ability to effectively implement a hybrid work model, economic uncertainties and geo-political situations, technological disruptions and innovations such as artificial intelligence (“AI”), generative AI, the complex and evolving regulatory landscape including immigration regulation changes, our ESG vision, our capital allocation policy and expectations concerning our market position, future operations, margins, profitability, liquidity, capital resources, our corporate actions including acquisitions, and cybersecurity matters. Important factors that may cause actual results or outcomes to differ from those implied by the forward-looking statements are discussed in more detail in our US Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2026. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.
